U

Usona Institute

Non-profit medical research on psychedelic therapies

Director – Quality Assurance & Compliance

Regulatory & Quality (Life Sciences)Confirmed live in the last 24 hours
Full-timeMadison, WI, USANo salary listed

About the Job

Requirements

  • A bachelor's degree in life sciences, pharmacy, chemistry, or a related field is required; an advanced degree is preferred.
  • At least 10 years of progressive pharmaceutical quality assurance experience, including at least 5 years in a leadership role.
  • Demonstrated experience supporting NDA, BLA, or equivalent regulatory submissions in a quality assurance capacity.
  • Direct experience with FDA BIMO inspections as a sponsor representative, quality assurance reviewer, or inspection host.
  • Deep working knowledge of GxP regulations, including GCP (ICH E6(R3)), GMP (21 CFR Parts 210/211), GLP, and 21 CFR Parts 50, 56, and 312.
  • Experience leading or overseeing a Quality Management System, including management review, governance, and executive reporting, such as in a Management Representative or QMS lead role in regulated GxP or ISO environments.
  • Hands-on experience administering an electronic Quality Management System, such as ETQ, MasterControl, Veeva, or equivalent.
  • Experience developing and executing a GxP audit program, including CRO and CMO oversight.
  • Strong written communication skills and experience writing or reviewing regulatory submissions, SOPs, CAPA records, and audit reports.
  • Demonstrated ability to build collaborative relationships in small-team environments and to earn trust before driving change.
  • Ability to use AI-assisted tools for regulatory research, gap analysis, SOP review, inspection preparation, document review, and audit-trail analysis, applying professional judgment to AI outputs.
  • Ability to ensure AI-assisted quality processes are documented, validated where required, and defensible under FDA inspection.
  • Ability to use Microsoft Office applications, mobile platforms, and electronic quality management systems; adapt to emerging technologies, including artificial intelligence.
  • Ability to remain stationary for several hours while reviewing documents, participating in video conferences, and using computer applications.
  • Ability to read, review, and analyze regulatory documents, SOPs, and compliance records for extended periods.
  • Ability to communicate verbally and in writing during regulatory meetings, inspections, vendor audits, and internal quality reviews, and to present complex regulatory information to diverse audiences.
  • Ability to traverse manufacturing facilities, clinical trial sites, and laboratory environments while maintaining GxP compliance and safety protocols.
  • Ability and willingness to travel 15–25% annually, including to FDA facilities, manufacturing and contract laboratories, clinical trial sites, and vendor locations; travel may increase during NDA submission preparation and FDA inspection periods.

Responsibilities

  • Own the quality components of the NDA filing and ensure supporting documentation meets FDA expectations.
  • Review and sign off on CTD modules with quality content, including Module 3 sections for drug substance and drug product.
  • Ensure open CAPAs, deviations, and protocol deviations are closed, documented, and supported by adequate root-cause investigations before submission.
  • Work with Regulatory Affairs to confirm regulatory submissions referenced in the NDA are on file and current, including IND safety reports and annual reports.
  • Confirm quality agreements are current with CMOs, contract laboratories, and CROs contributing to the submission package.
  • Maintain the Trial Master File in audit-ready condition through the filing date.
  • Maintain awareness of REMS framework requirements under discussion with Regulatory Affairs and provide QA input on ETASU design during NDA review.
  • Lead and complete mock BIMO inspection activities with internal and external resources.
  • Conduct or commission vendor audits to identify and remediate findings before FDA inspection.
  • Own the sponsor oversight narrative, including the monitoring plan, monitoring visit reports, site qualification documentation, and central monitoring records.
  • Develop the document-request response protocol and ensure personnel understand their roles during inspection.
  • Review SOPs to confirm clinical and quality documents are current and defensible.
  • Maintain deviation and complaint logs, resolve outstanding items, and prepare the QA narrative for the inspection team.
  • Serve as Usona’s senior quality leader and designated quality authority accountable for active regulatory programs.
  • Prepare and facilitate Management Review and provide QA sign-off on official records.
  • Administer or oversee the electronic Quality Management System for QA-owned documents.
  • Maintain and execute the GxP audit program, including annual vendor audits, audit reporting, and CAPA follow-through.
  • Ensure complaint management, CAPA, deviation, and batch-record review processes follow SOPs and are audit ready.
  • Own the Approved Vendor List, including annual review, new-vendor qualification routing, and quality-agreement execution.
  • Support the build-out of post-market safety-reporting infrastructure with medical and regulatory personnel.
  • Contribute to REMS material development, ETASU elements, and prescriber and pharmacy certification programs with Regulatory Affairs.
  • Establish a product complaint and quality-event system suited to a commercial-stage controlled substance.
  • Support post-approval FDA inspections, including routine GMP and post-market inspections.
  • Partner with Regulatory Affairs and CMC to establish the quality framework for new IND filings and early-phase clinical programs.
  • Extend vendor qualification, batch-record review, and deviation-management processes to new programs.
  • Apply learnings from the lead program to build efficient quality infrastructure for pipeline programs from day one.
  • Build out the Usona QA function as the organization grows, assess staffing needs, and make the case for resources as the portfolio expands.
  • Develop training programs and onboarding protocols for new QA-adjacent staff.
  • Serve as the institutional knowledge holder for quality processes and regulatory inspection history.
  • Represent Usona’s quality posture in interactions with FDA, auditors, investigators, and partners.
  • Ensure organizational compliance with 21 CFR Parts 50, 56, 312, 210/211, ICH E6(R3), and applicable FDA guidance.
  • Own sponsor-level GxP compliance, including investigator qualification, informed-consent oversight, protocol-deviation management, and SAE reporting.
  • Manage IND annual reports, safety reporting, and regulatory correspondence in coordination with Regulatory Affairs.
  • Monitor evolving FDA guidance and ICH standards and translate regulatory changes into operational process updates.
  • Own and operate the Usona QMS, including document control, CAPA, deviations, complaints, audits, vendor qualification, and management review.
  • Ensure the electronic QMS is maintained in a state of continuous inspection readiness.
  • Develop and update SOPs, policies, and work instructions for all quality functions.
  • Ensure 21 CFR Part 11 compliance for electronic records, audit trails, and electronic-signature functions.
  • Serve as the QA representative for active clinical programs through regulatory submission and post-approval follow-up.
  • Own sponsor oversight obligations, including the monitoring plan, site audit program, central monitoring review, and Trial Master File maintenance.
  • Review and sign off on protocol amendments, DSURs, study plans, and clinical regulatory documents.
  • Attend protocol-deviation review meetings and provide quality oversight of safety events and deviations.
  • Qualify and oversee critical vendors, including CMOs and CROs.
  • Execute and maintain quality agreements with all GxP service providers.
  • Lead or coordinate vendor audits and ensure CAPA follow-through on audit findings.
  • Use AI-assisted tools for regulatory research, gap analysis, SOP review, and inspection preparation, applying professional judgment to AI outputs.
  • Use regulatory intelligence capabilities for real-time guidance on GxP and FDA standards as they apply to active programs.
  • Apply AI-assisted document review and audit-trail analysis to improve the efficiency and depth of QA oversight.
  • Contribute to AI-assisted quality workflows by identifying where automation improves consistency and where human judgment remains essential.
  • Document AI-assisted QA processes, validate them where required, and ensure they are defensible under FDA inspection.

Desired Qualifications

  • Experience with Schedule I or II controlled-substance research programs, including DEA compliance, security protocols, and inventory management.
  • Experience developing REMS materials or post-market safety-reporting infrastructure.
  • Familiarity with CNS or psychiatric drug development.
  • Experience in a small sponsor or emerging biotech environment where QA is a multifunctional role.
  • Exposure to AI-assisted quality tools, regulatory intelligence platforms, or computerized-system validation in a GxP context.
  • CQA (Certified Quality Auditor) or equivalent professional certification.

About the Company

Usona Institute

Non-profit medical research on psychedelic therapies

Usona Institute is a non-profit medical research organization focused on studying the therapeutic use of psilocybin and other consciousness-expanding medicines. It conducts and supports both pre-clinical and clinical trials to understand how these substances can relieve depression and anxiety in patients who do not respond well to existing treatments. The research typically involves administering psilocybin in controlled clinical settings with professional medical oversight and psychotherapy to explore its potential benefits and risks. Unlike for-profit biotech firms, Usona centers on advancing scientific knowledge and patient care, prioritizing safety, accessibility, and transparency. Its goal is to develop evidence-based psychedelic therapies that can help people achieve a better quality of life when conventional treatments fall short.

Company size
11-50
Company stage
Not listed
Total funding
Not listed
Headquarters
Fitchburg, WI
Founded
2014

Recently Posted Jobs

Explore more opportunities at Usona Institute

See more jobs